Identifying Serious Fungal Infections Requiring Systemic Antifungal Therapy Evaluation and Treatment

Serious fungal infections affecting lungs, blood, brain, or other body systems demand urgent professional evaluation and aggressive systemic antifungal treatment. Recognizing warning patterns enables rapid intervention preventing life threatening complications. Persistent cough lasting more than three weeks, particularly with fever and night sweats, suggests serious lung fungal infection. Fungal pneumonia develops gradually with progressive respiratory symptoms. Chest imaging often shows infiltrates before respiratory symptoms become severe. Fever that persists despite antibacterial treatment suggests possible fungal infection. Fungal organisms don't respond to bacterial antibiotics. Normal antibiotics curing the infection's absence indicates need for fungal testing. Fungal blood stream infection presents with fever, chills, sepsis signs, and hemodynamic instability. These serious infections require rapid diagnosis through blood cultures and imaging. Early antifungal treatment prevents overwhelming sepsis. Fungal meningitis causes fever, severe headache, neck stiffness, and confusion. This life threatening infection requires emergency evaluation and imaging confirmation. Fungal meningitis mortality remains high even with appropriate treatment. Early diagnosis improves survival probability. Blastomycosis affecting skin and lungs causes progressive respiratory symptoms and skin ulceration. These fungal infections sometimes remain undiagnosed for months allowing serious tissue damage. Professional evaluation clarifies fungal infection presence. Coccidioidomycosis causes mild respiratory symptoms that sometimes progress to serious lung disease. Valley fever primarily affects people in specific geographic regions. Professional evaluation determines infection severity and treatment necessity. Learn about itraconazole treatment for serious fungal infections during professional evaluation. Systemic antifungal therapy requires careful monitoring for effectiveness and side effects. Healthcare providers determine appropriate treatment duration. Fungal culture and microscopy identify specific organisms affecting patients. Positive cultures confirm fungal infection and guide medication selection. Some fungal infections require specialized identification techniques before treatment determines optimal. Immunocompromised patients including those with HIV disease, solid organ transplant recipients, and those receiving active chemotherapy face significantly higher serious fungal infection risk statistically. These high risk populations need more aggressive early intervention even with mild symptoms suggesting possible fungal involvement. Geographic exposure including travel to areas with endemic fungi increases specific fungal infection risk. Discussing travel history with your healthcare provider helps guide fungal testing when respiratory symptoms develop. For comprehensive information about serious fungal infection evaluation, diagnostic testing, and evidence based systemic antifungal treatment protocols, explore professional approaches to systemic fungal infection management. Professional evaluation enables timely treatment preventing serious fungal infection complications and mortality risks from delayed diagnosis.

Antibiotics don’t speed recovery from asthma attacks

By Harvard Health Blog

Does winter in the Northeast make you think of snowmen, warm fires, and hot chocolate? Or, does it instead inspire visions of runny noses, congestion, and cough? Although it is less rosy, I know readers with asthma may be picturing the latter.
People with asthma get respiratory infections more often

In general, people with asthma tend to get sick more easily, and illnesses can trigger asthma attacks. In my practice, we generally start seeing an increase in the number of asthma attacks, or asthma flares, once the ground frosts. If you are fortunate enough not to have asthma, chances are that you know somebody who does. The Centers for Disease Control and Prevention  reports that rates of asthma in the United States are soaring, such that today, 1 in 12 people has it. Because people with asthma get sick more often, it is logical to suspect that they will often be prescribed antibiotics. But do antibiotics really help? New research is helping to answer this very question.
Do antibiotics help people with asthma get back to normal faster?

A study recently published in the Journal of American Medicine Association looked at the effectiveness of an antibiotic called azithromycin for treating asthma attacks. The trial, nicknamed AZALEA, aimed to look at whether adding azithromycin to the usual treatment helped people recover from asthma attacks more quickly.  This was of interest to the researchers for several reasons: For starters, azithromycin is a very commonly prescribed antibiotic, so it is important to know if it works. Also, studies showed that an older drug called telithromycin actually did help people heal from asthma attacks more quickly. Doctors rarely prescribe telithromycin today because it can cause serious side effects. But azithromycin is similar in many ways, so it might be a good alternative.
Azithromycin did not help the asthma attacks  improve

Participants in the study were separated into two groups. One group was given usual treatment for an asthma attack (a high potency anti-inflammatory pill and breathing treatments), plus azithromycin. The other group was given standard treatment for an asthma attack plus a placebo, or sugar pill. To help reduce confusion, the researchers excluded asthma sufferers who had taken antibiotics — for any reason — during the four weeks prior to the study.. At the end of the study, the researchers concluded that both groups recovered from their asthma attacks at the same speed.

This means  azithromycin did not make people recover any better or any faster, and those that did not receive  azithromycin still got better.
So, should you take antibiotics for asthma? No, but there are rare exceptions

There are several take-aways  from this study. First, azithromycin did not make any difference in making people with asthma attacks feel better. As a clinician, this makes a lot of sense to me. Azithromycin was the most commonly prescribed antibiotic in the U.S. in 2010, and remains heavily prescribed today. But it’s popularity comes at a cost. Many of the bacteria that typically cause respiratory infections in adults have become resistant to it. Furthermore, most adults with asthma attacks will have viral respiratory infections, and antibiotics don’t  kill viruses. That’s why I rarely prescribe an antibiotic for an asthma attack. When I do, I rarely prescribe azithromycin, because it will only work on a small fraction of bacteria. There are certainly some exceptions; smokers, in particular, can be different. But overall, the results of this study make intuitive sense.

A second, and very interesting, conclusion was that 90% of the asthmatics initially considered for  entry into this study had received antibiotics in the preceding month! We don’t know why these antibiotics were prescribed, but the rate of antibiotics prescribed for people with asthma is concerning. Common sense makes me suspect that this is too high a rate of antibiotic prescription. I’ve never yet had the need to give 9 out of 10 patients I see antibiotics. This makes me worry that antibiotics may be over-prescribed in asthmatics, and I would like to know why.

I hope that everyone out there has as healthy a winter as possible, filled only with snowmen, warm fires, and hot chocolate. For the asthma sufferers out there, I hope you know that research like this helps us providers learn how to take care of you better. And that is a very warm thought.

Source: http://www.health.harvard.edu/blog/antibiotics-dont-speed-recovery-asthma-attacks-2017010410941

Antibiotics and similar drugs, together called antimicrobial agents, have been used for the last 70 years to treat patients. Read bout Sulfamethoxazole/trimethoprim; cotrimoxazole (Bactrim, Bactrim DS, Septra, Septra DS), a drug prescribed for UTIs, ear infections, pneumonia and other. moxicillin, Amox in short is another penicillin based antibiotics of the beta lactam group for the treatment of infections caused by bacteria. Factory farms administer antibiotics to farm animals to promote growth and compensate for filthy conditions. Co-trimoxazole is used to treat certain bacterial infections, such as pneumonia (a lung infection), bronchitis (infection of the tubes leading to the lungs). Use the Antibiotic Selector to quickly search or browse for the best antibiotic based on your application. Also take advantage of this tool to find antibiotic usage.